Juliet Tammenoms Bakker, Director at RxSight, Inc. (RXST), bought 5,000 shares at $61.09 ($305K) on 2024-05-17, disclosed to the SEC on 2024-05-21.
Open-market purchase of $305k RXST by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Something here stands out, but not much.
| Filing → |
| RXST | SELL | 2023-11-30 | $29.4M | — | Filing → |
| RXST | SELL | 2023-11-16 | $13.6M | — | Filing → |
| RXST | SELL | 2023-09-11 | $2.0M | — | Filing → |